Emerging Infectious Diseases, ISSN 1080-6040, 08/2011, Volume 17, Issue 8, pp. 1541 - 1543
Since 2006, canine distemper outbreaks have occurred in rhesus monkeys at a breeding farm in Guangxi, People's Republic of China. Approximately 10,000 animals...
NATURAL INFECTION | INFECTIOUS DISEASES | CATS | VIRUS | PANDAS | TERRESTRIAL CARNIVORES | IMMUNOLOGY | Distemper - virology | Distemper - mortality | Monkey Diseases - virology | Distemper Virus, Canine - genetics | Distemper Virus, Canine - isolation & purification | China - epidemiology | Incidence | Viral Vaccines - administration & dosage | Distemper Virus, Canine - classification | Distemper Virus, Canine - immunology | Macaca mulatta - virology | Monkey Diseases - prevention & control | Animals | Distemper - epidemiology | Dogs | Animal Husbandry | Disease Outbreaks - veterinary | Distemper - prevention & control | Viral Vaccines - immunology | Monkey Diseases - epidemiology | Epidemics | Rhesus monkey | Care and treatment | Demographic aspects | China | Research | Diagnosis | Health aspects | Canine distemper virus | Canine distemper | measles-like infection | viruses | canine distemper | canine distemper virus | rhesus monkeys | epidemic | People’s Republic of China | Dispatch
NATURAL INFECTION | INFECTIOUS DISEASES | CATS | VIRUS | PANDAS | TERRESTRIAL CARNIVORES | IMMUNOLOGY | Distemper - virology | Distemper - mortality | Monkey Diseases - virology | Distemper Virus, Canine - genetics | Distemper Virus, Canine - isolation & purification | China - epidemiology | Incidence | Viral Vaccines - administration & dosage | Distemper Virus, Canine - classification | Distemper Virus, Canine - immunology | Macaca mulatta - virology | Monkey Diseases - prevention & control | Animals | Distemper - epidemiology | Dogs | Animal Husbandry | Disease Outbreaks - veterinary | Distemper - prevention & control | Viral Vaccines - immunology | Monkey Diseases - epidemiology | Epidemics | Rhesus monkey | Care and treatment | Demographic aspects | China | Research | Diagnosis | Health aspects | Canine distemper virus | Canine distemper | measles-like infection | viruses | canine distemper | canine distemper virus | rhesus monkeys | epidemic | People’s Republic of China | Dispatch
Journal Article
Vaccine, ISSN 0264-410X, 07/2019, Volume 37, Issue 30, pp. 4022 - 4030
The amino terminus of human papillomavirus (HPV) minor capsid protein L2 harbors several conserved neutralizing epitopes, including aa.17–36 (RG-1 epitope) and...
Papillomavirus | Flagellin | Mucosal immunization | Neutralizing antibody | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS | VACCINES PROTECT | HUMAN-PAPILLOMAVIRUS | N-TERMINUS | IMMUNOLOGY | MINOR CAPSID PROTEIN | CHALLENGE | EPITOPE | IMMUNE-RESPONSES | INTRANASAL IMMUNIZATION | CROSS-PROTECTIVE EFFICACY | Medical colleges | Biological products | Viral proteins | Analysis | Lactoferrins | Immunoglobulin A | Recombinant proteins | Papillomavirus infections | Antigenic determinants | Salmonella | Capsid protein | Peptides | Hemodialysis | Mucosa | Antibodies | Vaccines | Proteins | Human papillomavirus | E coli | Fusion protein | Public health | Recombinant | Antigens | Immunization | Immunoglobulins | Vagina | Stability analysis | C-Terminus | Epitopes | Secretions | Gene banks | Construction costs | Immunogenicity | Plasmids | Neutralizing | Cancer
Papillomavirus | Flagellin | Mucosal immunization | Neutralizing antibody | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS | VACCINES PROTECT | HUMAN-PAPILLOMAVIRUS | N-TERMINUS | IMMUNOLOGY | MINOR CAPSID PROTEIN | CHALLENGE | EPITOPE | IMMUNE-RESPONSES | INTRANASAL IMMUNIZATION | CROSS-PROTECTIVE EFFICACY | Medical colleges | Biological products | Viral proteins | Analysis | Lactoferrins | Immunoglobulin A | Recombinant proteins | Papillomavirus infections | Antigenic determinants | Salmonella | Capsid protein | Peptides | Hemodialysis | Mucosa | Antibodies | Vaccines | Proteins | Human papillomavirus | E coli | Fusion protein | Public health | Recombinant | Antigens | Immunization | Immunoglobulins | Vagina | Stability analysis | C-Terminus | Epitopes | Secretions | Gene banks | Construction costs | Immunogenicity | Plasmids | Neutralizing | Cancer
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 1/2012, Volume 205, Issue 2, pp. 237 - 243
Background. The production of Sabin inactivated polio virus vaccine (IPV) can reduce biosafety requirements in the posteradication/post-oral poliovirus vaccine...
Inactivated poliovirus vaccine | Immune response | Oral poliovirus vaccine | Poliomyelitis | Vaccination | Antibodies | Viruses | Lost to follow up | Poliovirus | Dosage | INFECTIOUS DISEASES | MICROBIOLOGY | IMMUNOLOGY | Poliovirus Vaccine, Oral - immunology | Confidence Intervals | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Poliovirus Vaccine, Oral - adverse effects | Infant | Male | Poliomyelitis - immunology | Chi-Square Distribution | Poliovirus Vaccine, Oral - administration & dosage | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Poliovirus - immunology | Poliovirus Vaccine, Inactivated - adverse effects | Female | Health aspects | Poliomyelitis vaccine | Testing
Inactivated poliovirus vaccine | Immune response | Oral poliovirus vaccine | Poliomyelitis | Vaccination | Antibodies | Viruses | Lost to follow up | Poliovirus | Dosage | INFECTIOUS DISEASES | MICROBIOLOGY | IMMUNOLOGY | Poliovirus Vaccine, Oral - immunology | Confidence Intervals | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Poliovirus Vaccine, Oral - adverse effects | Infant | Male | Poliomyelitis - immunology | Chi-Square Distribution | Poliovirus Vaccine, Oral - administration & dosage | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Poliovirus - immunology | Poliovirus Vaccine, Inactivated - adverse effects | Female | Health aspects | Poliomyelitis vaccine | Testing
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 01/2019, Volume 91, Issue 1, pp. 22 - 30
To analyze the effects of phenol red at various pH values on the Sabin type 2 inactivated polio vaccine (sIPV2), several biophysical techniques were used to...
phenol red | zeta potential | stabilization | inactivated polio vaccine (IPV) | THERMAL-STABILITY | HUMAN HOLO-TRANSFERRIN | THERMOSTABILIZATION | BINARY | HEAVY-WATER | VIROLOGY | FLUORESCENCE | POLIOVACCINE | PROTEINS | Phenols | Vaccines | Hydrogen-ion concentration | Poliomyelitis | Enzyme-linked immunosorbent assay | Stability | Capsid protein | Light scattering | Scattering | Tryptophan | Fluorescence | Particulates | Viruses | Agglomeration | Photon correlation spectroscopy | pH effects | Circular dichroism | Proteins | Transmission electron microscopy | Zeta potential | Dichroism | pH | Protein structure
phenol red | zeta potential | stabilization | inactivated polio vaccine (IPV) | THERMAL-STABILITY | HUMAN HOLO-TRANSFERRIN | THERMOSTABILIZATION | BINARY | HEAVY-WATER | VIROLOGY | FLUORESCENCE | POLIOVACCINE | PROTEINS | Phenols | Vaccines | Hydrogen-ion concentration | Poliomyelitis | Enzyme-linked immunosorbent assay | Stability | Capsid protein | Light scattering | Scattering | Tryptophan | Fluorescence | Particulates | Viruses | Agglomeration | Photon correlation spectroscopy | pH effects | Circular dichroism | Proteins | Transmission electron microscopy | Zeta potential | Dichroism | pH | Protein structure
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 01/2019, Volume 91, Issue 1, pp. 14 - 21
Background At the same dosage, the new generation of Sabin‐inactivated poliovirus vaccine (sIPV) is less immunogenic than the traditional oral polio vaccine...
long duration | geometric mean titer | seroconversion | adjuvant | polio vaccine | IMMUNE-RESPONSE | CARBOMER | STRATEGY | MF59 ADJUVANT | DELIVERY | IMMUNIZATION | VIROLOGY | ERADICATION | Antigens | Aluminum hydroxide | Vaccines | Immunization | Animals | Immunogenicity | Aluminum | Rodents | Alum | Dosage | Seroconversion | Neutralization
long duration | geometric mean titer | seroconversion | adjuvant | polio vaccine | IMMUNE-RESPONSE | CARBOMER | STRATEGY | MF59 ADJUVANT | DELIVERY | IMMUNIZATION | VIROLOGY | ERADICATION | Antigens | Aluminum hydroxide | Vaccines | Immunization | Animals | Immunogenicity | Aluminum | Rodents | Alum | Dosage | Seroconversion | Neutralization
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 10/2019, Volume 91, Issue 10, pp. 1729 - 1736
Background Polio eradication has been achieved in the world except for three countries due to the widespread use of the inactivated poliovirus vaccine (IPV)...
differentially expressed genes | bioinformatical analysis | polio vaccination | IMMUNITY | IMMUNOGENICITY | VIROLOGY | DENDRITIC CELLS | BIOLOGY | MONOCYTES | CYTOSCAPE | Antigens | Poliomyelitis | Analysis | Genes | Vaccination | Genetic research | Vaccines | CD40 antigen | Websites | Antigen processing | Lipids | Hormones | Data bases | Proteins | Cell activation | Databases | Bioinformatics | Immune system | Antigen presentation | Immunization | Immune response | Cytokines | Gene expression | Biological activity | Monocytes | Major histocompatibility complex | Antigen-presenting cells | Interferon
differentially expressed genes | bioinformatical analysis | polio vaccination | IMMUNITY | IMMUNOGENICITY | VIROLOGY | DENDRITIC CELLS | BIOLOGY | MONOCYTES | CYTOSCAPE | Antigens | Poliomyelitis | Analysis | Genes | Vaccination | Genetic research | Vaccines | CD40 antigen | Websites | Antigen processing | Lipids | Hormones | Data bases | Proteins | Cell activation | Databases | Bioinformatics | Immune system | Antigen presentation | Immunization | Immune response | Cytokines | Gene expression | Biological activity | Monocytes | Major histocompatibility complex | Antigen-presenting cells | Interferon
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 35, Issue 5, pp. 831 - 841
Abstract Background Studies have shown that HIV infection is associated with an impaired influenza vaccine response. We examined the role of cellular...
Allergy and Immunology | Immunologic responders and non-responders | B cells | Influenza vaccine | HIV disease | Influenza A Virus, H1N1 Subtype - immunology | Influenza Vaccines - administration & dosage | B7-1 Antigen - genetics | Apoptosis - drug effects | Humans | Middle Aged | Vaccination | Male | CD40 Ligand - immunology | Case-Control Studies | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | B-Lymphocytes - virology | Adult | Anti-HIV Agents - therapeutic use | Female | Influenza, Human - virology | Seasons | CD4-Positive T-Lymphocytes - virology | Antibodies, Viral - biosynthesis | Gene Expression | B7-1 Antigen - immunology | HIV-1 - drug effects | HIV Infections - virology | CD4 Lymphocyte Count | Influenza A Virus, H1N1 Subtype - drug effects | Antiretroviral Therapy, Highly Active | B-Lymphocytes - drug effects | HIV-1 - immunology | Apoptosis - immunology | B-Lymphocytes - immunology | CD40 Ligand - genetics | Antibodies, Neutralizing - biosynthesis | HIV Infections - drug therapy | Immunologic Memory | Influenza, Human - prevention & control | CD4-Positive T-Lymphocytes - drug effects | Influenza, Human - immunology | Influenza vaccines | Antiviral agents | Control | Influenza | HIV patients | HIV (Viruses) | T cells | HIV infection | Apoptosis | Highly active antiretroviral therapy | Analysis | Health aspects | Flow cytometry | Plasma | Immunoglobulins | Research & development--R&D | Viruses | Infections | Vaccines | Studies | Acquired immune deficiency syndrome--AIDS | Swine flu | Lymphocytes | Rodents | Human immunodeficiency virus--HIV | influenza vaccine | immunologic responders and non-responders
Allergy and Immunology | Immunologic responders and non-responders | B cells | Influenza vaccine | HIV disease | Influenza A Virus, H1N1 Subtype - immunology | Influenza Vaccines - administration & dosage | B7-1 Antigen - genetics | Apoptosis - drug effects | Humans | Middle Aged | Vaccination | Male | CD40 Ligand - immunology | Case-Control Studies | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | B-Lymphocytes - virology | Adult | Anti-HIV Agents - therapeutic use | Female | Influenza, Human - virology | Seasons | CD4-Positive T-Lymphocytes - virology | Antibodies, Viral - biosynthesis | Gene Expression | B7-1 Antigen - immunology | HIV-1 - drug effects | HIV Infections - virology | CD4 Lymphocyte Count | Influenza A Virus, H1N1 Subtype - drug effects | Antiretroviral Therapy, Highly Active | B-Lymphocytes - drug effects | HIV-1 - immunology | Apoptosis - immunology | B-Lymphocytes - immunology | CD40 Ligand - genetics | Antibodies, Neutralizing - biosynthesis | HIV Infections - drug therapy | Immunologic Memory | Influenza, Human - prevention & control | CD4-Positive T-Lymphocytes - drug effects | Influenza, Human - immunology | Influenza vaccines | Antiviral agents | Control | Influenza | HIV patients | HIV (Viruses) | T cells | HIV infection | Apoptosis | Highly active antiretroviral therapy | Analysis | Health aspects | Flow cytometry | Plasma | Immunoglobulins | Research & development--R&D | Viruses | Infections | Vaccines | Studies | Acquired immune deficiency syndrome--AIDS | Swine flu | Lymphocytes | Rodents | Human immunodeficiency virus--HIV | influenza vaccine | immunologic responders and non-responders
Journal Article
8.
Full Text
Construction high‐yield candidate influenza vaccine viruses in Vero cells by reassortment
Journal of Medical Virology, ISSN 0146-6615, 11/2016, Volume 88, Issue 11, pp. 1914 - 1921
Usage of influenza vaccine is the best choice measure for preventing and conclusion of influenza virus infection. Although it has been used of chicken embryo...
influenza vaccine | reassortment | Vero cells adaption | Influenza vaccine | Reassortment | A VIRUS | H5N1 | IMMUNOGENICITY | VIROLOGY | HEMAGGLUTININ | SAFETY | GROWTH | GENERATION | B VIRUS | Influenza A Virus, H1N1 Subtype - immunology | Orthomyxoviridae Infections - prevention & control | Guinea Pigs | Humans | Cercopithecus aethiops | Reassortant Viruses - genetics | Influenza A Virus, H3N2 Subtype - genetics | Influenza A Virus, H3N2 Subtype - immunology | Influenza A Virus, H1N1 Subtype - growth & development | Reassortant Viruses - growth & development | Antigens, Viral - isolation & purification | Influenza A Virus, H3N2 Subtype - growth & development | Reassortant Viruses - immunology | Animals | Influenza Vaccines - immunology | Chickens | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Influenza, Human - prevention & control | Orthomyxoviridae Infections - virology | Vero Cells | Orthomyxoviridae Infections - immunology | Influenza, Human - immunology | Influenza viruses | Influenza vaccines | Influenza
influenza vaccine | reassortment | Vero cells adaption | Influenza vaccine | Reassortment | A VIRUS | H5N1 | IMMUNOGENICITY | VIROLOGY | HEMAGGLUTININ | SAFETY | GROWTH | GENERATION | B VIRUS | Influenza A Virus, H1N1 Subtype - immunology | Orthomyxoviridae Infections - prevention & control | Guinea Pigs | Humans | Cercopithecus aethiops | Reassortant Viruses - genetics | Influenza A Virus, H3N2 Subtype - genetics | Influenza A Virus, H3N2 Subtype - immunology | Influenza A Virus, H1N1 Subtype - growth & development | Reassortant Viruses - growth & development | Antigens, Viral - isolation & purification | Influenza A Virus, H3N2 Subtype - growth & development | Reassortant Viruses - immunology | Animals | Influenza Vaccines - immunology | Chickens | Influenza, Human - virology | Influenza A Virus, H1N1 Subtype - genetics | Influenza, Human - prevention & control | Orthomyxoviridae Infections - virology | Vero Cells | Orthomyxoviridae Infections - immunology | Influenza, Human - immunology | Influenza viruses | Influenza vaccines | Influenza
Journal Article
Journal of Leukocyte Biology, ISSN 0741-5400, 12/2017, Volume 102, Issue 6, pp. 1481 - 1486
Autoantibodies binding on CD4+ T cells may mediate CD4+ T cell death, and prevent CD4+ T cell recovery in aviremic HIV‐infected patients under ART. Although...
disease | autoantibody | ART | HIV infection | Autoantibody | Disease | AUTOANTIBODIES | MORTALITY | ACTIVATION | DEPLETION | PATTERNS | IMMUNOLOGY | SUPPRESSION | FAILURE | CELL BIOLOGY | INDIVIDUALS | REPLICATION | HEMATOLOGY | RECONSTITUTION | HIV Infections - blood | Immunoglobulin G - blood | Autoantibodies - blood | Humans | Middle Aged | Male | CD4 Lymphocyte Count | Antiretroviral Therapy, Highly Active | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Apoptosis - immunology | Killer Cells, Natural - immunology | Protein Binding | Adult | Female | HIV Infections - drug therapy | Cytotoxicity, Immunologic | Plasma | Flow cytometry | Therapy | Toxicity | Immunoglobulin G | Cytotoxicity | Lymphocytes T | Recovery | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | Human immunodeficiency virus--HIV | Natural killer cells | Drug therapy | Binding | Antiretroviral drugs | Autoantibodies | Complications | Mortality | Patients | Morbidity | Antiretroviral therapy | CD4 antigen | Cytometry | Cell death | Cell number | Apoptosis | Translational & Clinical Immunology
disease | autoantibody | ART | HIV infection | Autoantibody | Disease | AUTOANTIBODIES | MORTALITY | ACTIVATION | DEPLETION | PATTERNS | IMMUNOLOGY | SUPPRESSION | FAILURE | CELL BIOLOGY | INDIVIDUALS | REPLICATION | HEMATOLOGY | RECONSTITUTION | HIV Infections - blood | Immunoglobulin G - blood | Autoantibodies - blood | Humans | Middle Aged | Male | CD4 Lymphocyte Count | Antiretroviral Therapy, Highly Active | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Apoptosis - immunology | Killer Cells, Natural - immunology | Protein Binding | Adult | Female | HIV Infections - drug therapy | Cytotoxicity, Immunologic | Plasma | Flow cytometry | Therapy | Toxicity | Immunoglobulin G | Cytotoxicity | Lymphocytes T | Recovery | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | Human immunodeficiency virus--HIV | Natural killer cells | Drug therapy | Binding | Antiretroviral drugs | Autoantibodies | Complications | Mortality | Patients | Morbidity | Antiretroviral therapy | CD4 antigen | Cytometry | Cell death | Cell number | Apoptosis | Translational & Clinical Immunology
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 12/2016, Volume 40, Issue 5, pp. 921 - 932
Background: There are sporadic cases and local outbreaks of H5N1 avian influenza virus worldwide every year. The World Health Organization (WHO) has paid close...
Original Paper | Meta | PHYSIOLOGY | VIRUS | Avian influenza vaccines | HEMAGGLUTININ | A/H5N1 VACCINE | TRIAL | H5N1 | RESPONSES | Immunogenicity | DOUBLE-BLIND | Adjuvant | CROSS-REACTIVE IMMUNITY | A/VIETNAM/1194/2004 | PHASE-I | Virion - immunology | Pandemics | Adjuvants, Immunologic | Health | Humans | Influenza Vaccines - adverse effects | Clinical Trials as Topic | Vaccines, Subunit - immunology | Influenza Vaccines - immunology | Influenza A Virus, H5N1 Subtype - immunology | Adult | Influenza, Human - virology | Influenza, Human - immunology
Original Paper | Meta | PHYSIOLOGY | VIRUS | Avian influenza vaccines | HEMAGGLUTININ | A/H5N1 VACCINE | TRIAL | H5N1 | RESPONSES | Immunogenicity | DOUBLE-BLIND | Adjuvant | CROSS-REACTIVE IMMUNITY | A/VIETNAM/1194/2004 | PHASE-I | Virion - immunology | Pandemics | Adjuvants, Immunologic | Health | Humans | Influenza Vaccines - adverse effects | Clinical Trials as Topic | Vaccines, Subunit - immunology | Influenza Vaccines - immunology | Influenza A Virus, H5N1 Subtype - immunology | Adult | Influenza, Human - virology | Influenza, Human - immunology
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 2016, Volume 214, Issue 11, pp. 1728 - 1734
Background. The development of a Sabin strain-based inactivated poliovirus vaccine (Sabin-IPV) is imperative to protecting against vaccine-associated paralytic...
Poliovirus | Sabin strain | Inactivated vaccine | INFECTIOUS DISEASES | SAFETY | MICROBIOLOGY | ENDGAME | IMMUNOLOGY | IPV | IMMUNOGENICITY | inactivated vaccine | POLIOMYELITIS | ERADICATION | MICE | EPIDEMIOLOGY | poliovirus | Double-Blind Method | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Poliovirus Vaccine, Inactivated - adverse effects | Female | Immunization Schedule | Infant | Male | Poliomyelitis - prevention & control | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Poliomyelitis vaccine | Research
Poliovirus | Sabin strain | Inactivated vaccine | INFECTIOUS DISEASES | SAFETY | MICROBIOLOGY | ENDGAME | IMMUNOLOGY | IPV | IMMUNOGENICITY | inactivated vaccine | POLIOMYELITIS | ERADICATION | MICE | EPIDEMIOLOGY | poliovirus | Double-Blind Method | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Poliovirus Vaccine, Inactivated - adverse effects | Female | Immunization Schedule | Infant | Male | Poliomyelitis - prevention & control | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Poliomyelitis vaccine | Research
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 11/2016, Volume 88, Issue 11, pp. 1914 - 1921
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 34, Issue 16, pp. 1945 - 1955
Abstract Background There is increasing recognition of the role of B cell dysfunction in HIV pathogenesis, but little is known about how these perturbations...
Allergy and Immunology | Antibody responses | B cells | Influenza vaccine | HIV disease | MEDICINE, RESEARCH & EXPERIMENTAL | PANDEMIC INFLUENZA | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | H1N1/09 VACCINE | PLASMACYTOID DENDRITIC CELLS | INHIBITORS ACTIVATE | UNFOLDED PROTEIN RESPONSE | ACTIVE ANTIRETROVIRAL THERAPY | ANTIBODY-RESPONSE | T-CELLS | Influenza A Virus, H3N2 Subtype | Influenza Vaccines - administration & dosage | Humans | Middle Aged | Male | Neutralization Tests | Antibodies, Viral - blood | Case-Control Studies | Hemagglutination Inhibition Tests | HIV Infections - immunology | Immunity, Humoral | Influenza A Virus, H1N1 Subtype | RNA, Ribosomal, 16S - isolation & purification | Adult | Female | Anti-Retroviral Agents - therapeutic use | Lymphocyte Activation | CD4 Lymphocyte Count | Bacterial Translocation | B-Lymphocytes - immunology | Influenza Vaccines - immunology | RNA, Bacterial - isolation & purification | HIV Infections - drug therapy | Immunity, Cellular | Influenza, Human - prevention & control | Antibodies, Neutralizing - blood | Apoptosis | Influenza vaccines | Medical colleges | Care and treatment | Control | Analysis | Communicable diseases | Influenza | Vaccination | HIV patients | Drug discovery | HIV (Viruses) | HIV infection | Antigens | Antiviral agents | Microbiology | T cells | Highly active antiretroviral therapy | Antiretroviral drugs | Flow cytometry | Plasma | Research & development--R&D | Laboratories | Mortality | Infections | Vaccines | Studies | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | influenza vaccine | antibody responses
Allergy and Immunology | Antibody responses | B cells | Influenza vaccine | HIV disease | MEDICINE, RESEARCH & EXPERIMENTAL | PANDEMIC INFLUENZA | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | H1N1/09 VACCINE | PLASMACYTOID DENDRITIC CELLS | INHIBITORS ACTIVATE | UNFOLDED PROTEIN RESPONSE | ACTIVE ANTIRETROVIRAL THERAPY | ANTIBODY-RESPONSE | T-CELLS | Influenza A Virus, H3N2 Subtype | Influenza Vaccines - administration & dosage | Humans | Middle Aged | Male | Neutralization Tests | Antibodies, Viral - blood | Case-Control Studies | Hemagglutination Inhibition Tests | HIV Infections - immunology | Immunity, Humoral | Influenza A Virus, H1N1 Subtype | RNA, Ribosomal, 16S - isolation & purification | Adult | Female | Anti-Retroviral Agents - therapeutic use | Lymphocyte Activation | CD4 Lymphocyte Count | Bacterial Translocation | B-Lymphocytes - immunology | Influenza Vaccines - immunology | RNA, Bacterial - isolation & purification | HIV Infections - drug therapy | Immunity, Cellular | Influenza, Human - prevention & control | Antibodies, Neutralizing - blood | Apoptosis | Influenza vaccines | Medical colleges | Care and treatment | Control | Analysis | Communicable diseases | Influenza | Vaccination | HIV patients | Drug discovery | HIV (Viruses) | HIV infection | Antigens | Antiviral agents | Microbiology | T cells | Highly active antiretroviral therapy | Antiretroviral drugs | Flow cytometry | Plasma | Research & development--R&D | Laboratories | Mortality | Infections | Vaccines | Studies | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | influenza vaccine | antibody responses
Journal Article
Gastroenterology, ISSN 0016-5085, 2013, Volume 144, Issue 3, pp. 624 - 635.e4
Background & Aims Formin-like (FMNL)2 is up-regulated in colorectal tumors and has been associated with tumor progression, but little is known about regulatory...
Gastroenterology and Hepatology | Tumor Suppressor Activity | Gene Expression | Signaling Pathway | Mouse Model | PATHWAYS | MAPK | LINES | MELANOMA | CARCINOGENESIS | MIR-137 | GENES | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | CARCINOMA | MOTILITY | Neoplasm Transplantation | MicroRNAs - antagonists & inhibitors | Neoplasm Invasiveness | Down-Regulation | Humans | 3' Untranslated Regions - genetics | Male | MicroRNAs - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | HMGA1a Protein - metabolism | Mitogen-Activated Protein Kinase Kinases - metabolism | Neoplasm Metastasis | Animals | Proteins - metabolism | Mice, Nude | Cell Line, Tumor | Mice | MicroRNAs - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins c-akt - metabolism | Genes, Tumor Suppressor | Colorectal Neoplasms - metabolism | Medical colleges | Chromosomal proteins | MicroRNA | Pregnant women | Analysis | Colorectal cancer | Metastasis | Gene expression | Vascular endothelial growth factor | Mitogens
Gastroenterology and Hepatology | Tumor Suppressor Activity | Gene Expression | Signaling Pathway | Mouse Model | PATHWAYS | MAPK | LINES | MELANOMA | CARCINOGENESIS | MIR-137 | GENES | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | CARCINOMA | MOTILITY | Neoplasm Transplantation | MicroRNAs - antagonists & inhibitors | Neoplasm Invasiveness | Down-Regulation | Humans | 3' Untranslated Regions - genetics | Male | MicroRNAs - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | HMGA1a Protein - metabolism | Mitogen-Activated Protein Kinase Kinases - metabolism | Neoplasm Metastasis | Animals | Proteins - metabolism | Mice, Nude | Cell Line, Tumor | Mice | MicroRNAs - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins c-akt - metabolism | Genes, Tumor Suppressor | Colorectal Neoplasms - metabolism | Medical colleges | Chromosomal proteins | MicroRNA | Pregnant women | Analysis | Colorectal cancer | Metastasis | Gene expression | Vascular endothelial growth factor | Mitogens
Journal Article
15.
Full Text
Reliability of pseudotyped influenza viral particles in neutralizing antibody detection
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e113629
Background: Current influenza control strategies require an active surveillance system. Pseudotyped viral particles (pp) together with the evaluation of...
NEURAMINIDASE | POPULATION | IMMUNITY | VIRUS | ASSAY | MATCHING PATTERNS | HEMAGGLUTININ | HEPATITIS | CHINA | MULTIDISCIPLINARY SCIENCES | INFECTION | Influenza A Virus, H1N1 Subtype - immunology | Virion - immunology | Humans | Middle Aged | Cells, Cultured | Influenza, Human - blood | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Influenza A Virus, H5N1 Subtype - isolation & purification | Hemagglutination Inhibition Tests | Young Adult | Reassortant Viruses - immunology | Animals | Influenza A Virus, H1N1 Subtype - isolation & purification | Influenza A Virus, H5N1 Subtype - immunology | Adolescent | Dogs | HEK293 Cells | Madin Darby Canine Kidney Cells | Adult | Antibodies, Viral - immunology | Influenza, Human - virology | Influenza, Human - immunology | Viral antibodies | Antibodies | Comparative analysis | Pandemics | Laboratories | Fluorescence | Viruses | Vaccines | Surveying | Hemagglutination inhibition | Immunity | Confidence intervals | Hemagglutination | Neutralizing | Influenza | Hemagglutinins | Immunity (humoral) | Trends | Reliability | Active control | Enzyme-linked immunosorbent assay
NEURAMINIDASE | POPULATION | IMMUNITY | VIRUS | ASSAY | MATCHING PATTERNS | HEMAGGLUTININ | HEPATITIS | CHINA | MULTIDISCIPLINARY SCIENCES | INFECTION | Influenza A Virus, H1N1 Subtype - immunology | Virion - immunology | Humans | Middle Aged | Cells, Cultured | Influenza, Human - blood | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Influenza A Virus, H5N1 Subtype - isolation & purification | Hemagglutination Inhibition Tests | Young Adult | Reassortant Viruses - immunology | Animals | Influenza A Virus, H1N1 Subtype - isolation & purification | Influenza A Virus, H5N1 Subtype - immunology | Adolescent | Dogs | HEK293 Cells | Madin Darby Canine Kidney Cells | Adult | Antibodies, Viral - immunology | Influenza, Human - virology | Influenza, Human - immunology | Viral antibodies | Antibodies | Comparative analysis | Pandemics | Laboratories | Fluorescence | Viruses | Vaccines | Surveying | Hemagglutination inhibition | Immunity | Confidence intervals | Hemagglutination | Neutralizing | Influenza | Hemagglutinins | Immunity (humoral) | Trends | Reliability | Active control | Enzyme-linked immunosorbent assay
Journal Article